Showing results (61-70 of 293) with videos related to
Sort By:
Pageof 30
Current Opinion in Immunology|November 5, 2002
Making and breaking tolerancePamela S Ohashi, Anthony L DeFrancoClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2017
Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory TargetHeather L MacGregor, Pamela S OhashiTrends in Cell Biology|July 7, 2020
The Roles of CD8+ T Cell Subsets in Antitumor ImmunityMichael St Paul, Pamela S OhashiEuropean Journal of Immunology|February 27, 2014
Mir-155, a central modulator of T-cell responsesEvan F Lind, Pamela S OhashiNature Reviews. Immunology|December 24, 2014
Clinical blockade of PD1 and LAG3--potential mechanisms of actionLinh T Nguyen, Pamela S OhashiJCI Insight|October 7, 2021
Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2Kevin M Gao, Alan G Derr, Zhiru Guo, et al.Journal of Leukocyte Biology|August 18, 2016
Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent?Sudesh Pawaria, Shruti Sharma, Rebecca Baum, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2016
Synergy between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of DNase II-/-IFNaR-/- MiceRebecca Baum, Kerstin Nündel, Sudesh Pawaria, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Cutting edge: AIM2 and endosomal TLRs differentially regulate arthritis and autoantibody production in DNase II-deficient miceRebecca Baum, Shruti Sharma, Susan Carpenter, et al.Proceedings of the National Academy of Sciences of the United States of America|April 5, 2019
Hierarchy of clinical manifestations in SAVI N153S and V154M mouse modelsMona Motwani, Sudesh Pawaria, Jennifer Bernier, et al.Pageof 30